Project Details
Description
An open-label, randomized study to evaluate the safety, tolerability and efficacy of tocilizumab (TCZ) monotherapy or TCZ in combination with non-biologic DMARDs in patients with active rheumatoid arthritis who have an inadequate response to current non
| Status | Finished |
|---|---|
| Effective start/end date | 6/19/09 → 1/12/10 |
Funding
- ROCHE LAB INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.